Sno Swedish Arctic Gel Recovery

Description

Sno Swedish Arctic Gel Recovery is a topical formulation designed for recovery and relief. The product is presented in a gel dosage form, characterized by its lightweight and non-greasy texture. It is formulated to provide a soothing effect upon application, making it suitable for use on the skin. The gel is designed to be absorbed quickly, delivering its active ingredients effectively to the targeted area. The appearance of the gel is clear to slightly opaque, with a consistency that allows for easy application.

Uses and Indications

This drug is indicated for the topical treatment of localized pain in adults and children over 12 years of age. It is to be applied as a thin layer to the affected area and massaged into the skin until thoroughly absorbed. The application may be repeated as necessary, not exceeding four times daily.

For children 12 years of age or younger, it is advised to consult a healthcare professional before use.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The topical analgesic is to be applied directly to the affected area of the skin. Healthcare professionals should ensure that the skin is clean and dry prior to application. The recommended dosage may vary based on the severity of the condition being treated and the specific product formulation.

Patients should be instructed to apply a thin layer of the analgesic to the affected area, typically 2 to 4 times daily, or as directed by a healthcare provider. It is important to avoid applying the product to broken or irritated skin.

For optimal results, the analgesic should be massaged gently into the skin until fully absorbed. Healthcare professionals should monitor patients for any adverse reactions and adjust the frequency of application as necessary based on individual response and tolerance.

Contraindications

There are no specific contraindications listed for this product. However, it is advised to discontinue use and consult a healthcare professional if any of the following conditions occur: worsening of the condition, presence of redness, development of irritation, or if symptoms persist for more than 7 days or resolve and recur within a few days.

Warnings and Precautions

This product is intended for external use only. It is imperative that healthcare professionals advise patients to use this product strictly as directed. Patients should be cautioned against tightly bandaging the area of application or using it in conjunction with a heating pad, as these practices may exacerbate adverse effects.

Contact with the eyes or mucous membranes must be avoided to prevent irritation or injury. Additionally, this product should not be applied to wounds or damaged skin, as this may lead to further complications.

Patients should be instructed to discontinue use and consult a healthcare provider if any of the following occur: the condition worsens, redness develops, irritation arises, or symptoms persist for more than 7 days. If symptoms resolve and then recur within a few days, medical advice should also be sought.

In the event of accidental ingestion, immediate medical assistance should be obtained, or the patient should contact a Poison Control Center without delay.

Side Effects

Patients using this product may experience adverse reactions, which can be categorized into warnings and conditions that necessitate discontinuation of use and consultation with a healthcare professional.

For external use only, this product should be applied strictly as directed. Patients are advised against bandaging tightly or using the product in conjunction with a heating pad. It is crucial to avoid contact with the eyes or mucous membranes, and the product should not be applied to wounds or damaged skin.

Patients should discontinue use and seek medical advice if any of the following occur: worsening of the condition, presence of redness, development of irritation, or if symptoms persist for more than 7 days. Additionally, if symptoms resolve and then recur within a few days, medical consultation is recommended.

Drug Interactions

There are no reported drug interactions associated with the use of this medication. Additionally, no interactions with laboratory tests have been identified. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Sno Swedish Arctic Gel Recovery (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients 12 years of age or younger should consult a healthcare professional before use. It is important to assess the appropriateness of treatment and dosage for this age group, as specific recommendations may vary based on individual health needs and conditions.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of guidance necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms may vary depending on the specific substance involved, and monitoring for any adverse effects is essential.

Management procedures should include a thorough assessment of the patient's condition, including vital signs and any presenting symptoms. Supportive care may be necessary, and specific treatment protocols should be followed based on the substance involved and the severity of the overdosage.

In all cases, timely communication with poison control and adherence to established medical guidelines are recommended to ensure optimal patient care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important for patients to be aware that they should discontinue use and consult a doctor if their condition worsens or if they notice any redness. Additionally, patients should be instructed to stop using the product and seek medical advice if they experience any irritation.

Patients should also be informed that if their symptoms persist for more than 7 days, or if the symptoms clear up and then recur within a few days, they should stop using the product and consult a healthcare professional. This guidance is essential for ensuring patient safety and effective management of their condition.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a temperature range of 68-77°F (20-25°C) to maintain its integrity and efficacy. Additionally, the product must be protected from excessive moisture to ensure optimal quality and performance. Proper handling and storage conditions are crucial for preserving the product's stability.

Additional Clinical Information

The product is administered topically. For adults and children over 12 years, a thin layer should be applied to the affected area and massaged into the skin until fully absorbed, with a maximum frequency of four times daily as needed. For children aged 12 years or younger, it is advised to consult a doctor before use.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Sno Swedish Arctic Gel Recovery, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)